Systems Biology of Lipid Metabolism
Organizer(s): Matej Orešic, Antonio J. Vidal-Puig and Ana Maria CuervoDate: February 09 - 13, 2015
Location: Beaver Run Resort, Breckenridge, CO, USA
Lipid homeostasis is fundamental to the maintenance of good health. Due to the enormous functional and structural diversity of lipids as well as their complex regulation at multiple spatial and temporal scales, lipids need to be studied not only at the level of biological pathways but also at the level of the biophysical systems they are part of, including cellular membranes or lipoprotein particles. From the perspective of systems biology, this adds an additional but necessary layer of complexity to the studies of lipids. This Keystone Symposia meeting will cover recent progress and perspectives in the studies of lipids as related to: 1) Cellular as well as systemic lipid metabolism; 2) Computational modeling of lipids; and 3) The role of lipids in the pathogenesis of several complex diseases including metabolic, immune and central nervous system disorders as well as cancer. Specifically, experts in this area will address whether alterations in lipid biology may be an important underlying pathogenic link among these disorders, which could explain the well documented metabolic co-morbidities such as between obesity and several other complex diseases. The meeting will bring together a highly interdisciplinary and outstanding group of scientists including biochemists, molecular and cellular biologists, clinical researchers and computational biologists. Such a diverse mix will facilitate the cross-disciplinary interactions needed to address current key questions in lipid biology in the context of translational medicine, as well as move the field of lipids forward by consolidating the use of systems biology approaches to study their involvement in the pathogenesis of common diseases.
Scholarship Deadline: October 14 2014
Discounted Abstract Deadline: October 14 2014
Abstract Deadline: November 13 2014
Discounted Registration Deadline: December 10 2014
We gratefully acknowledge additional support for this conference from:
We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:
Eli Lilly and Company
We gratefully acknowledge the generous grant for this conference provided by:National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Grant No. 1R13DK104458-01
Funding for this conference was made possible (in part) by 1 R13 DK104458-01 from NIDDK. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.